ALDER BIOPHARMACEUTICALS INC Earnings Per Share (Diluted)
ALDER BIOPHARMACEUTICALS INC reported Earnings Per Share (Diluted) of -$3.23 per share for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-23.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2017-02-23
- ALDER BIOPHARMACEUTICALS INC earnings per share, diluted for the quarter ending 2015-12-31 was -$0.60.
- ALDER BIOPHARMACEUTICALS INC earnings per share, diluted for the quarter ending 2015-09-30 was -$0.62, a 170.45% decline year-over-year.
- ALDER BIOPHARMACEUTICALS INC earnings per share, diluted for the quarter ending 2015-06-30 was -$0.46.
- ALDER BIOPHARMACEUTICALS INC earnings per share, diluted for the quarter ending 2015-03-31 was -$0.40.
- ALDER BIOPHARMACEUTICALS INC earnings per share, diluted for fiscal 2016 was -$3.23.
- ALDER BIOPHARMACEUTICALS INC earnings per share, diluted for fiscal 2015 was -$2.11, a 803.33% decline from fiscal 2014.
- ALDER BIOPHARMACEUTICALS INC earnings per share, diluted for fiscal 2014 was $0.30.
- ALDER BIOPHARMACEUTICALS INC earnings per share, diluted for fiscal 2013 was -$21.14.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2016-12-31 | -$3.23 10-K · filed 2017-02-23 | |||
| 2015-12-31 | -$0.60 10-K · filed 2016-02-23 | -$1.22 derived: net income ÷ weighted average shares · filed 2017-02-23 | -$2.11 10-K · filed 2017-02-23 | |
| 2015-09-30 | -$0.62 10-K · filed 2016-02-23 | -$1.50 10-Q · filed 2015-11-05 | ||
| 2015-06-30 | -$0.46 10-K · filed 2016-02-23 | |||
| 2015-03-31 | -$0.40 10-K · filed 2016-02-23 | |||
| 2014-12-31 | -$0.22 10-K · filed 2016-02-23 | $0.66 derived: net income ÷ weighted average shares · filed 2017-02-23 | $0.30 10-K · filed 2017-02-23 | |
| 2014-09-30 | $0.88 10-K · filed 2016-02-23 | $0.56 10-Q · filed 2015-11-05 | ||
| 2014-06-30 | -$0.40 10-K · filed 2016-02-23 | |||
| 2014-03-31 | -$5.38 10-K · filed 2016-02-23 | |||
| 2013-12-31 | -$3.94 10-K · filed 2015-03-13 | -$9.99 derived: net income ÷ weighted average shares · filed 2016-02-23 | -$21.14 10-K · filed 2016-02-23 | |
| 2013-09-30 | -$6.05 10-K · filed 2015-03-13 | -$17.21 10-Q · filed 2014-11-03 | ||
| 2013-06-30 | -$5.27 10-K · filed 2015-03-13 | |||
| 2013-03-31 | -$5.89 10-K · filed 2015-03-13 | |||
| 2012-12-31 | -$19.54 10-K · filed 2015-03-13 |